Can teatime increase one's lifetime?

Ageing Research Reviews

Volumn 2, Issue 1, 2003, Pages 1-10

  Nakachi, Kei ^a   Eguchi, Hidetaka ^a   Imai, Kazue ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

All death; Cancer; Cardiovascular disease; Cohort study; Green tea; Lifespan

Indexed keywords

ADULT; AGED; AGING; CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; JAPAN; LIFESPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; QUESTIONNAIRE; REVIEW; TEA;

EID: 0345257977     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(02)00047-8     Document Type: Article

References (27)

1. Arts I.C., Hollman P.C., Feskens E.J., Bueno de Mesquita H.B., Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly study. Am. J. Clin. Nutr. 74:2001;227-232.
2. Conney A.H., Lu Y.-P., Lou Y.-R., Xie J.-G., Huang M.T. Inhibitory effect of green and black tea on tumor growth. Proc. Soc. Exptl. Biol. Med. 220:1999;229-233.
3. Fujiki H. Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol. 125:1999;589-597.
4. Fujiki H., Suganuma M., Okabe S., Sueoka E., Suga K., Imai K., Nakachi K. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea - a review. Cancer Detect. Prev. 24:2000;91-99.
5. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Dai Q., Fraumeni J.F. Jr. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86:1994;855-858.
6. Hakim I.A., Harris R.B., Weisgerber U.M. Tea intake and squamous cell carcinoma of the skin: influence of type of tea beverages. Cancer Epidemiol. Biomarkers Prev. 9:2000;727-731.
7. Hollman P.C., Feskens E.J., Katan M.B. Tea flavonols in cardiovascular disease and cancer epidemiology. Proc. Soc. Exp. Biol. Med. 220:1999;198-202.
8. Imai K., Nakachi K. Cross-sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 310:1995;693-696.
9. Imai K., Suga K., Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26:1997;769-775.
10. Inoue M., Tajima K., Hirose K., Hamajima N., Takezaki T., Kuroishi T., Tominaga S. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 9:1998;209-216.
11. Joseph S.L., Arab L. Tea consumption and the reduced risk of colon cancer - results from a national prospective cohort study. Public Health Nutr. 5:2002;419-426.
12. Kono S., Ikeda M., Tokutome S., Kuratsune M. A case-control study of gastric cancer and diet in Northern Kyushu, Japan. Jpn. J. Cancer Res. 79:1988;1067-1074.
13. Muramatsu K., Fukuyo M., Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 32:1986;613-622.
14. Nagano J., Kono S., Preston D.L., Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control. 12:2001;501-508.
15. Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors. 13:2000;49-54.
16. NCI, DCPC, Chemoprevention Branch and Agent Development Committee, 1996. Clinical development plan: tea extracts, green tea polyphenols, epigallocatechin gallate. J. Cell Biochem. 26S, 236-257.
17. Ohno Y., Wakai K., Genka K., Ohmine K., Kawamura T., Tamakoshi A., Aoki R., Senda M., Hayashi Y., Nagao K., Fukuma S., Aoki K. Tea consumption and lung cancer risk a case-control study in Okinawa, Japan. Jpn. J. Cancer Res. 86:1995;1027-1034.
18. Peters U., Poole C., Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am. J. Epidemiol. 154:2001;495-503.
19. Setiawan V.W., Zhang Z.F., Yu G.P., Lu Q.Y., Li Y.L., Lu M.L., Wang M.R., Guo C.H., Yu S.Z., Kurtz R.C., Hsieh C.C. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer. 92(4):2001;600-604.
20. Suganuma M., Okabe S., Sueoka N., Sueoka E., Matsuyama S., Imai K., Nakachi K., Fujiki H. Green tea and cancer chemoprevention. Mutat. Res. 428:1999;339-344.
21. Suganuma M., Sueoka E., Sueoka N., Okabe S., Fujiki H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. BioFactors. 13:2000;67-72.
22. Tsubono Y., Nishino Y., Komatsu S., Hsieh C.C., Kanemura S., Tsuji I., Nakatsuka H., Fukao A., Satoh H., Hisamichi S. Green tea and the risk of gastric cancer in Japan. New Engl. J. Med. 344(9):2001;632-636.
23. Vinson J.A. Black and green tea and heart disease: a review. BioFactors. 13:2000;127-132.
24. Yang C.S., Wang Z.Y. Tea and cancer. J. Natl. Cancer Inst. 85:1993;1038-1049.
25. Yang C.S., Chung J.Y., Yang G.-Y., Li C., Meng X., Lee M.J. Mechanisms of inhibition of carcinogenesis by tea. BioFactors. 13:2000;73-79.
26. Yoshizawa S., Horiuchi T., Fujiki H., Yoshida T., Okuda T., Sugimura T. Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea. Phytother. Res. 1:1987;44-47.
27. Zheng W., Doyle T.J., Kushi L.H., Sellers T.A., Hong C.P., Folsom A.R. Tea consumption and cancer incidence in a prospective cohort study of post-menopausal women. Am. J. Epidemiol. 144:1996;175-182.